(GEN) Gen Digital - Ratings and Ratios
Antivirus, Vpn, Identity, Cleanup, Optimization
GEN EPS (Earnings per Share)
GEN Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 27.0% |
| Value at Risk 5%th | 40.2% |
| Relative Tail Risk | -9.44% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.45 |
| Alpha | -24.34 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.479 |
| Beta | 0.934 |
| Beta Downside | 1.040 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.66% |
| Mean DD | 11.30% |
| Median DD | 10.35% |
Description: GEN Gen Digital October 16, 2025
Gen Digital Inc. (NASDAQ: GEN) provides cyber-safety solutions to consumers, families and small businesses through a portfolio that includes Norton, Avast, LifeLock, MoneyLion, Avira, AVG and CCleaner. The firm’s offerings span security and performance management, identity protection, online privacy and a technology platform. Formerly NortonLifeLock, the company rebranded to Gen Digital in November 2022 and is headquartered in Tempe, Arizona.
Key metrics from the most recent fiscal year show revenue of roughly $2.2 billion, with an adjusted EBITDA margin near 15 % and a subscriber base exceeding 50 million paid users. Growth is being driven by rising consumer demand for privacy tools and the broader macro trend of increasing corporate cybersecurity spend, which the IDC forecasts to grow at a CAGR of ~12 % through 2027. A notable sector pressure is the tightening of data-protection regulations (e.g., GDPR, CCPA), which tends to boost demand for identity-theft protection services.
If you want to dig deeper into GEN’s valuation assumptions and scenario analysis, ValueRay’s analytics platform can help you model the impact of different growth and margin trajectories.
GEN Stock Overview
| Market Cap in USD | 15,871m |
| Sub-Industry | Application Software |
| IPO / Inception | 1990-03-26 |
| Return 12m vs S&P 500 | -21.1% |
| Analyst Rating | 4.0 of 5 |
GEN Dividends
| Dividend Yield | 1.87% |
| Yield on Cost 5y | 2.91% |
| Yield CAGR 5y | -55.28% |
| Payout Consistency | 86.5% |
| Payout Ratio | 20.8% |
GEN Growth Ratios
| CAGR 3y | 7.85% |
| CAGR/Max DD Calmar Ratio | 0.23 |
| CAGR/Mean DD Pain Ratio | 0.69 |
| Current Volume | 5083.9k |
| Average Volume | 3832.9k |
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income (570.0m TTM) > 0 and > 6% of Revenue (6% = 268.4m TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA -5.60pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -28.24% (prev -67.46%; Δ 39.23pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 1.32b > Net Income 570.0m (YES >=105%, WARN >=100%) |
| Net Debt (8.00b) to EBITDA (1.21b) ratio: 6.61 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.51 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (624.0m) change vs 12m ago 0.32% (target <= -2.0% for YES) |
| Gross Margin 79.32% (prev 80.38%; Δ -1.06pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 28.38% (prev 24.91%; Δ 3.47pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.13 (EBITDA TTM 1.21b / Interest Expense TTM 890.0m) >= 6 (WARN >= 3) |
Altman Z'' 0.14
| (A) -0.08 = (Total Current Assets 1.29b - Total Current Liabilities 2.55b) / Total Assets 16.05b |
| (B) 0.01 = Retained Earnings (Balance) 217.0m / Total Assets 16.05b |
| (C) 0.06 = EBIT TTM 1.00b / Avg Total Assets 15.76b |
| (D) 0.18 = Book Value of Equity 2.46b / Total Liabilities 13.59b |
| Total Rating: 0.14 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 63.46
| 1. Piotroski 2.0pt = -3.0 |
| 2. FCF Yield 5.45% = 2.72 |
| 3. FCF Margin 29.06% = 7.27 |
| 4. Debt/Equity 3.54 = -1.52 |
| 5. Debt/Ebitda 6.61 = -2.50 |
| 6. ROIC - WACC (= -1.84)% = -2.30 |
| 7. RoE 24.67% = 2.06 |
| 8. Rev. Trend 77.92% = 5.84 |
| 9. EPS Trend 97.95% = 4.90 |
What is the price of GEN shares?
Over the past week, the price has changed by +3.61%, over one month by -0.48%, over three months by -14.93% and over the past year by -9.59%.
Is Gen Digital a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of GEN is around 23.26 USD . This means that GEN is currently overvalued and has a potential downside of -12.88%.
Is GEN a buy, sell or hold?
- Strong Buy: 4
- Buy: 1
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the GEN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 33.3 | 24.9% |
| Analysts Target Price | 33.3 | 24.9% |
| ValueRay Target Price | 25.6 | -4% |
GEN Fundamental Data Overview November 11, 2025
P/E Trailing = 28.3187
P/E Forward = 11.0497
P/S = 3.5482
P/B = 7.3123
P/EG = 0.9035
Beta = 1.111
Revenue TTM = 4.47b USD
EBIT TTM = 1.00b USD
EBITDA TTM = 1.21b USD
Long Term Debt = 7.97b USD (from longTermDebt, last fiscal year)
Short Term Debt = 280.0m USD (from shortTermDebt, last quarter)
Debt = 8.70b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.00b USD (from netDebt column, last quarter)
Enterprise Value = 23.87b USD (15.87b + Debt 8.70b - CCE 701.0m)
Interest Coverage Ratio = 1.13 (Ebit TTM 1.00b / Interest Expense TTM 890.0m)
FCF Yield = 5.45% (FCF TTM 1.30b / Enterprise Value 23.87b)
FCF Margin = 29.06% (FCF TTM 1.30b / Revenue TTM 4.47b)
Net Margin = 12.74% (Net Income TTM 570.0m / Revenue TTM 4.47b)
Gross Margin = 79.32% ((Revenue TTM 4.47b - Cost of Revenue TTM 925.0m) / Revenue TTM)
Gross Margin QoQ = 78.20% (prev 78.76%)
Tobins Q-Ratio = 1.49 (Enterprise Value 23.87b / Total Assets 16.05b)
Interest Expense / Debt = 5.26% (Interest Expense 458.0m / Debt 8.70b)
Taxrate = 42.49% (99.0m / 233.0m)
NOPAT = 576.3m (EBIT 1.00b * (1 - 42.49%))
Current Ratio = 0.51 (Total Current Assets 1.29b / Total Current Liabilities 2.55b)
Debt / Equity = 3.54 (Debt 8.70b / totalStockholderEquity, last quarter 2.46b)
Debt / EBITDA = 6.61 (Net Debt 8.00b / EBITDA 1.21b)
Debt / FCF = 6.15 (Net Debt 8.00b / FCF TTM 1.30b)
Total Stockholder Equity = 2.31b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.55% (Net Income 570.0m / Total Assets 16.05b)
RoE = 24.67% (Net Income TTM 570.0m / Total Stockholder Equity 2.31b)
RoCE = 9.75% (EBIT 1.00b / Capital Employed (Equity 2.31b + L.T.Debt 7.97b))
RoIC = 5.34% (NOPAT 576.3m / Invested Capital 10.79b)
WACC = 7.18% (E(15.87b)/V(24.57b) * Re(9.46%) + D(8.70b)/V(24.57b) * Rd(5.26%) * (1-Tc(0.42)))
Discount Rate = 9.46% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.64%
[DCF Debug] Terminal Value 73.87% ; FCFE base≈1.63b ; Y1≈1.69b ; Y5≈1.92b
Fair Price DCF = 42.82 (DCF Value 26.37b / Shares Outstanding 615.9m; 5y FCF grow 3.71% → 3.0% )
EPS Correlation: 97.95 | EPS CAGR: 12.36% | SUE: 0.67 | # QB: 0
Revenue Correlation: 77.92 | Revenue CAGR: 10.12% | SUE: 0.96 | # QB: 3
Additional Sources for GEN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle